MERCK & Co has announced
a major restructure of the firm’s
research and development
operations, as part of an “ongoing
commitment to streamline our
operating model and aggressively
manage our cost structure”.
Under the changes, research
head Rocher Perlmutter said
several senior positions had
been eliminated in the process,
which aimed to focus on the most
promising programs and speed up
drug development.
“Virtually everyone has expressed
frustration with our system of
governance and the complexity
of our organisational design,” he
wrote in an internal memo.
The new structure sees a senior
team in charge of all aspects of
R&D, from early drug discovery
right through to regulatory affairs.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jun 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jun 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.